Sahin-Tóth Miklós
Department of Molecular and Cell Biology, Goldman School of Dental Medicine, Boston University, 715 Albany Street, Evans-4, Boston, MA 02118, USA.
Endocrinol Metab Clin North Am. 2006 Jun;35(2):303-12, ix. doi: 10.1016/j.ecl.2006.02.002.
The past decade has witnessed remarkable progress in the genetics of chronic pancreatitis. Despite these accomplishments, the understanding of the molecular mechanisms through which PRSS1 and SPINK1 mutations cause chronic pancreatitis has remained sketchy. Pancreatitis-associated gene mutations are believed to result in uncontrolled trypsin activity in the pancreas. Experimental identification of the disease-relevant functional alterations caused by PRSS1 or SPINK1 mutations proved to be challenging, however, because results of biochemical analyses lent themselves to different interpretations. This article focuses on PRSS1 mutations and summarizes the salient biochemical findings in the context of the mechanistic models that explain the connection between mutations and hereditary pancreatitis.
过去十年见证了慢性胰腺炎遗传学方面的显著进展。尽管取得了这些成就,但对于PRSS1和SPINK1突变导致慢性胰腺炎的分子机制的理解仍然很粗略。胰腺炎相关基因突变被认为会导致胰腺中胰蛋白酶活性失控。然而,实验鉴定由PRSS1或SPINK1突变引起的与疾病相关的功能改变被证明具有挑战性,因为生化分析结果有不同的解读。本文重点关注PRSS1突变,并在解释突变与遗传性胰腺炎之间联系的机制模型背景下总结了主要的生化发现。